18F-FDG PET/CT Imaging in Sarcomatoid Hepatocellular Carcinoma. (14th May 2022)

• Record Type: Journal Article
• Authors: Yang, Ting; Zou, Min-Hong; Zou, Qiong; Jiao, Ju; Zhang, Yong
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 5(2022)
• Page Start: 427
• Page End: 429
• Publication Date: 2022-05-14
• Subjects: sarcomatoid hepatocellular carcinoma -- PET/CT -- PD-1; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000004121
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: Sarcomatoid hepatocellular carcinoma is a rare subtype of hepatocellular carcinoma. We present a 53-year-old man with a hepatic IV/VIII segment neoplasm whose tumor markers were all in the reference range. The neoplasm presented intense uptake of 18 F-FDG and was confirmed as sarcomatoid hepatocellular carcinoma by immunohistochemistry. After 6 cycles of PD-1 treatment, no recurrence or metastasis was found by follow-up CT over 2 years. Thus, we reported a case of sarcomatoid hepatocellular carcinoma with complete remission to PD-1 treatment and provided some help for the diagnosis and treatment of sarcomatoid hepatocellular carcinoma.